Fig. 4b
From: IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience
Overall survival according to mutational status in G2 patients. 5-years OS in G2 was 79% (95% CI: 47-93) for IDHmut vs 48% (95% CI: 27-66) for IDHwt (p 0.8543)